Inhibition of the myosin ATPase by vanadate ion (V1) has been studied in 90 mM NaCl/5 mM MgCl2/20 mM Tris HCI, pH 8.5, at 250C. Although the onset of inhibition during the assay is slow and dependent upon Vi concentration (kap -t 0.3 M-1 s-'), the final level of inhibition approaches iOO4o, provided the V; concentration is in slight excess over the concentration of ATPase sites. Inhibition is not reversible by dialysis or the addition of reducing agents. The source of this irreversible inhibition consists of the formation of a stable, inactive complex with the composition MADP-V1 (where M represents a single myosin active site). The complex has been isolated, and its mechanism of formation from M, ADP, and Vi has been studied. Omission of ATP increases the rate of formation by about 35-fold (kapp 11 M-1 s-'), yet this rate is still low in comparison with the rates of simple protein-ligand association reactions. This slowness is interpreted in terms of a rate-limiting isomerization step that follows the association of M, ADP, and V1: M*ADP*V1 _ Mt.ADP.V1 (t indicates the inactive product of the isomerization). (9) and Weeds and Taylor (10), respectively. The HMM fraction that precipitated between 45 and 60% saturated ammonium sulfate was dialyzed free of ammonium sulfate, centrifuged 30 min at 40,000 X g, and used within 10 days. The concentration of HMM was expressed in terms of the ATPase-site concentration, which was determined spectrophotometrically by using a value of A2801% = 6.47 (11), assuming a molecular weight of 340,000 and two ATPase sites per molecule.ATPase assays were carried out in buffer A (0.09 M NaCl/5 mM MgCl2/20 mM Tris-HCI, pH 8.5) at 250C by the addition of MgATP (final concentration, 1 mM) to HMM at 1-7 AM sites.Assay times ranged from 0.1 to 5 hr. The reaction was stopped in aliquots (1 ml) of the assay solution with 1 ml of 10% trichloroacetic acid. The aliquots were then clarified by centrifugation and half of each was analyzed for Pi by the procedure of Taussky and Shorr (12). V1 concentrations below 10 mM caused less than 1% interference.Vanadium Analysis. Stock solutions of V1 were prepared from either Na3VO4 (adjusted to pH 10 with 6 M HCl) or V205 (adjusted to pH 10 with 10 M NaOH) and then boiled to destroy yellow polymeric species such as V100286-(13). Standard solutions were prepared by volumetric dilution. In order to minimize the pH-dependent polymerization of Vi, all studies were carried out under the alkaline conditions used for the ATPase assays (buffer A). UV-visible spectra of Vi standard solutions were obtained by using a Cary 14 spectrophotometer, and the extinction coefficient was determined: Xrnax = 265 nm, C265 = 2925 M-1 cm-1. The Vi concentration was determined spectrophotometrically wherever possible.Where this was unfeasible (e.g., in the presence of protein), vanadium was determined by a modification of the colorimetric procedure of Pribil (14), using the metallochromic dye PAR.To a 1-ml sample in buffer A was added 100 Al of 1 M imidazole (pH 6.0) and ...
Actin-myosin subfragment-l (SF-1) or actin-heavy meromyosin is dissociated by the binding of ADP and vanadate (Vi) A recent study demonstrated the inhibition of myosin ATPase activity by vanadate (Vi) (1). The formation of an extremely stable myosin-ADP-vanadate complex (t112 of 1-2 days) provides an explanation of the mechanism of inhibition. Further studies to be published elsewhere have shown that the normal myosin-ADP complex binds vanadate weakly and undergoes a slow isomerization to form a stable complex that is a competitive inhibitorin which M indicates myosin. Considering the similarity in structure of vanadate and phosphate and that vanadate is bound stoichiometrically at or near the active site, the M-ADP-Vit complex may be a stable analogue of the myosin-ADP-phosphate intermediate, which is believed to be a key intermediate in the myosin and actomyosin ATPase mechanism (2).In the present study we have examined the reactions of vanadate with actomyosin to test the hypothesis that M-ADP-Vit is indeed an analogue of the myosin-products intermediate.This state, which is generally referred to as the M.ADP.Pi**, state is characterized by the following properties. The complex is much more wealdy bound to actin than is myosin alone or M-ADP (3, 4). The rates ofdissociation ofADP and Pi are greatly increased by forming a complex with actin, and this increase in rate accounts for the activation of myosin ATPase activity by actin. The control ofthe ATPase activity ofregulated actomyosin (AM) by calcium ion involves a change either in the association constant of M.ADP-Pi** to the actin-tropomyosin-troponin complex or in the rate of release of products from the AM.ADP.Pi** complex (5-7). The evidence to be presented here shows that the AM.ADP.Vit complex has the same properties. MATERIALS AND METHODSMyosin was prepared from rabbit back and leg muscles by the method described by Perry (8); actin was made by the procedure of Spudich and Watt (9); heavy meromyosin (HMM) and subfragment-1 (SF-1) were obtained by chymotryptic digestion ofmyosin and purified by the method ofWeeds and Taylor (10); native tropomyosin (the one-to-one complex of troponin and tropomyosin) was made by the procedure of Hitchcock (11).The myosin-ADP-vanadate complex was formed by incubation ofthe protein with 0.5 mM ADP and 1 or 2 mM vanadate for 15 min (1). Longer incubation times had no further effect on the state of the protein or the ability to quantitatively regenerate the ATPase activity. Free ADP and vanadate were removed when necessary by passage of the protein solution in pH 8.5 or pH 7.0 buffer over a 1-cm Dowex-1 X 8 column. In all experiments vanadate was added by dilution from a concentrated stock solution at pH 10 to avoid the possible formation of complex ions.Free vanadate was determined colorimetrically by reaction with 4-(2-pyridylazo)resorcinol (PAR) as described (1). The rate of color development was first order in vanadate and PAR concentrations over the ranges used in the experiments. Because protein-bound van...
The structural stabilities of all the familiar proteolytic fragments of myosin have been investigated in melting studies over the pH ranges 5.5-7.0 in 0.5 M KCl. All fragments except subfragment 2 undergo a melting transition manifested by the cooperative uptake of protons in the temperature range 34-47 degrees C, and these fragments experience an increase in transition temperature, Tm as the pH is increased. Subfragment 2 undergoes a melting transition in the 43-55 degrees C range, manifested by the dissociation of protons, and it experiences a decrease in Tm as the pH is increased. These results suggest that pH changes can modulate the relative stabilities of the light meromysin, subfragment-1, and subfragment-2 regions of the myosin molecule.
The melting behavior of myosin and myosin rod has been studied over the pH range 5.4-7.0, in 0.5 M KCl. Both proteins exhibit almost identical T-m values, which increase from about 37 to 43 degrees as the pH is elevated through the range of study, T-m follows a sigmoidal dependence upon pH, and the inflection point occurs near pH 6.5. The influence of salt concentration on T-m was studied, by the variation of KCl from 0.15 to 2.92 M. With an increasing KCl concentration, both proteins exhibit similar, sigmoidal declines in T-m from about 44 to 34 degrees. Under all conditions of pH and ionic strength studied, melting is accompanied by an absorption of H+ by the protein. The concentration of the protein, the age of the preparation, and the presence of divalent metal ions fail to exert a significant effect on the T-m values obtained by our methods. The effects of salt concentration and pH on the thermal stability of myosin and myosin rod are discussed in terms of the location of the melting process within the myosin molecule. Myosin is shown to possess several of the requisite features for energy transduction via a proton-coupling mechanism. These features provide a framework for investigating some aspects of the molecular basis of muscle contraction within the context of the sliding filament model.
1. The steady-state kinetic behaviour of the ATPase (adenosine triphosphatase) of intact myofibrils was studied in the presence of both high and low concentrations of Ca2+ (0.25 mM and less than 10 nM respectively). 2. Kinetic data were collected over the initial linear phase of the assay, which lasts for 20--60s. To obtain consistent data we found it necessary to use either fresh myofibril preparations or preparations that had been stored in the presence of thiol compounds. 3. When assayed in the presence of 0.25 mM-Ca2+, the myofibrillar ATPase obeyed Michaelis-Menten kinetics over the range 0.03--5.0 mM-MgATP (Km 16 +/- 6 micrometer, V 0.4 +/- 0.1 mumol/min per mg). 4. At low Ca2+ concentrations (less than 10 nM) the myofibrillar ATPase displayed pronounced substrate inhibition, which was not observed at high Ca2+ concentrations. Thus increasing the MgATP concentration had the net effect of decreasing the ATPase activity at low Ca2+ relative to that at high Ca2+. This preferential effect of MgATP on the low-Ca2+ ATPase may be important in Ca2+ control. 5. The substrate inhibition that was observed at low Ca2+ was lost on storage or thiol modification of the myofibrils. 6. Under physiological conditions (2 mM-MgATP, I 0.15, pH 7.0), the ATPase of fresh and thiol-protected myofibrils displayed approx. 100-fold activation by Ca2+.
The binding of ADP to heavy meromyosin has been studied by microcalorimetry. Minute amounts of myokinase interfere with binding measurements, but by selection of appropriate conditions, we can estimate that the value of the apparent deltaHbinding lies between - 1.0 and - 3.0 kcal per mole of ADP bound (0.3 M KC1, 2 mM MgC12, 20mM Tris, pH 8.00, 20 degrees C). Values of deltaHbinding reported to date are an order of magnitude larger, and we suggest that these values are artifactual results due to myokinase contamination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.